Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Low Dose Naltrexone for Pain in Patients With HIV — Stella

Home/Human Immunodeficiency Virus/Low Dose Naltrexone for Pain in Patients With HIV

View on ClinicalTrials.gov

Recruiting

Back to Human Immunodeficiency Virus trials

Low Dose Naltrexone for Pain in Patients With HIV

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(3 sites)

United States

Grady Memorial Hospital, Atlanta, Georgia

Emory Midtown Hospital, Atlanta, Georgia

Emory University Hospital, Atlanta, Georgia

Key details

Phase

Post-approval study

Sponsor

Emory University

Enrollment target

~60 participants

Started

April 2023

Primary completion

June 2027

Age range

18 Years – 75 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.